Abstract
Surveys on the relationships between medical academia and the pharmaceutical industry have raised concerns over potential conflicts of interest. To address the issues, more medical schools are establishing policies and taking steps to limit the pharmaceutical industry's presence and influence on campus, though with different approaches. Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
